Gene · 1364
Papers3,919
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 3,919
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| New developments in mesothelial pathology. | Histopathology | 2024 | 37694811 | PubTator, text mining | PubMed |
| Yogurt starter strains ameliorate intestinal barrier dysfunction via activating AMPK in Caco-2 cells. | Tissue Barriers | 2024 | 36852963 | PubTator, text mining | PubMed |
| An investigation of binding interactions of tumor-targeted peptide conjugated polyphenols with the kinase domain of ephrin B4 and B2 receptors. | Mol Divers | 2024 | 36847923 | PubTator, text mining | PubMed |
| Claudin-4 Upregulation in Acantholytic and Autoimmune-Mediated Bullous Disorders. | Dermatopathology (Basel) | 2023 | 38534263 | PubTator, text mining | PubMed |
| Expression of Claudin-4 and D2-40 and their significance in prostatic adenocarcinoma. | J Cancer Res Ther | 2023 | 38384059 | PubTator, text mining | PubMed |
| In vitro safety and functional characterization of the novel Bacillus coagulans strain CGI314. | Front Microbiol | 2023 | 38274758 | PubTator, text mining | PubMed |
| Intestinal Membrane Function in Inflammatory Bowel Disease. | Pharmaceutics | 2023 | 38258040 | PubTator, text mining | PubMed |
Sophy β-Glucan from the Black Yeast Aureobasidium pullulans Attenuates Salmonella-Induced Intestinal Epithelial Barrier Injury in Caco-2 Cell Monolayers via Exerting Anti-Oxidant and Anti-Inflammatory Properties. | Antioxidants (Basel) | 2023 | 38247473 | PubTator, text mining | PubMed |
| Corrigendum: Identification of differentially expressed hub genes associated with immune cell recruitment in claudin-low breast cancer. | Front Oncol | 2023 | 38239648 | PubTator, text mining | PubMed |
| Ketogenic Diet High in Saturated Fat Promotes Colonic Claudin Expression without Changes in Intestinal Permeability to Iohexol in Healthy Mice. | Nutrients | 2023 | 38201850 | PubTator, text mining | PubMed |
| Claudins-Promising Biomarkers for Selected Gastrointestinal (GI) Malignancies? | Cancers (Basel) | 2023 | 38201579 | PubTator, text mining | PubMed |
| Multilevel Heterogeneity of Colorectal Cancer Liver Metastasis. | Cancers (Basel) | 2023 | 38201487 | PubTator, text mining | PubMed |
| The Role of Cancer Stem Cell Markers in Ovarian Cancer. | Cancers (Basel) | 2023 | 38201468 | PubTator, text mining | PubMed |
| Fabp5 is a common gene between a high-cholesterol diet and acute pancreatitis. | Front Nutr | 2023 | 38188879 | PubTator, text mining | PubMed |
| Claudins in genitourinary tract neoplasms: mechanisms, prognosis, and therapeutic prospects. | Front Cell Dev Biol | 2023 | 38188015 | PubTator, text mining | PubMed |
| Emerging Applications of Liquid Biopsies in Ovarian Cancer. | Cureus | 2023 | 38174205 | PubTator, text mining | PubMed |
| The roles of short-chain fatty acids derived from colonic bacteria fermentation of non-digestible carbohydrates and exogenous forms in ameliorating intestinal mucosal immunity of young ruminants. | Front Immunol | 2023 | 38149240 | PubTator, text mining | PubMed |
| Expression of Claudin-9 (CLDN9) in Breast Cancer, the Clinical Significance in Connection with Its Subcoat Anchorage Proteins ZO-1 and ZO-3 and Impact on Drug Resistance. | Biomedicines | 2023 | 38137355 | PubTator, text mining | PubMed |
| Epithelial Barrier Dysfunction in Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) via Downregulation of Claudin-1. | Cells | 2023 | 38132165 | PubTator, text mining | PubMed |
| Identification of a core EMT signature that separates basal-like breast cancers into partial- and post-EMT subtypes. | Front Oncol | 2023 | 38111531 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1364/papers?page=14